Latest Insider Transactions at Blade Air Mobility, Inc. (BLDE)
This section provides a real-time view of insider transactions for Blade Air Mobility, Inc. (BLDE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Blade Air Mobility, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Blade Air Mobility, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,707
-3.57%
|
$14,828
$4.0 P/Share
|
|
Sep 10
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,018
-2.85%
|
$136,072
$4.0 P/Share
|
|
Sep 10
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,348
-2.64%
|
$141,392
$4.0 P/Share
|
|
Sep 10
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-0.78%
|
$9,512
$4.0 P/Share
|
|
Aug 29
2025
|
Robert S Wiesenthal Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,607
+0.76%
|
-
|
|
Aug 29
2025
|
Andrew Lauck Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,844
+8.31%
|
-
|
|
Aug 29
2025
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,844
+10.25%
|
-
|
|
Aug 14
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Direct |
22,365
+6.85%
|
-
|
|
Aug 07
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,945
+1.97%
|
$0
$0.18 P/Share
|
|
Aug 06
2025
|
Robert S Wiesenthal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
282,470
+4.39%
|
$0
$0.18 P/Share
|
|
Aug 06
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,500
+1.72%
|
$0
$0.18 P/Share
|
|
Aug 04
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Open market or private sale
|
Direct |
47,995
-4.01%
|
$191,980
$4.94 P/Share
|
|
Aug 04
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Open market or private sale
|
Direct |
46,918
-3.38%
|
$187,672
$4.94 P/Share
|
|
Aug 01
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
81,071
-6.34%
|
$243,213
$3.99 P/Share
|
|
Aug 01
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
160,714
+11.17%
|
-
|
|
Aug 01
2025
|
Robert S Wiesenthal Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136,263
-2.27%
|
$408,789
$3.99 P/Share
|
|
Aug 01
2025
|
Robert S Wiesenthal Director |
BUY
Grant, award, or other acquisition
|
Direct |
246,429
+3.94%
|
-
|
|
Aug 01
2025
|
Eric Affeldt Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+17.63%
|
-
|
|
Aug 01
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,426
-14.37%
|
$46,278
$3.99 P/Share
|
|
Aug 01
2025
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,143
+23.04%
|
-
|
|
Aug 01
2025
|
Edward M Philip Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+13.18%
|
-
|
|
Aug 01
2025
|
Andrew Lauck Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+23.02%
|
-
|
|
Aug 01
2025
|
Reginald Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+20.73%
|
-
|
|
Aug 01
2025
|
Kenneth B Lerer Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+17.63%
|
-
|
|
Aug 01
2025
|
Susan M Lyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+15.95%
|
-
|
|
Aug 01
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
76,177
-5.2%
|
$228,531
$3.99 P/Share
|
|
Aug 01
2025
|
William A. Heyburn Co-CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
139,286
+8.69%
|
-
|
|
Aug 01
2025
|
John Borthwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,534
+14.84%
|
-
|
|
Jun 10
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,348
-2.6%
|
$106,044
$3.8 P/Share
|
|
Jun 10
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,018
-2.96%
|
$102,054
$3.8 P/Share
|
|
Jun 10
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,708
-4.7%
|
$11,124
$3.8 P/Share
|
|
Jun 10
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,190
-0.77%
|
$6,570
$3.8 P/Share
|
|
Jun 10
2025
|
Robert S Wiesenthal Director |
SELL
Payment of exercise price or tax liability
|
Direct |
91,031
-1.56%
|
$273,093
$3.8 P/Share
|
|
Jun 09
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Open market or private sale
|
Direct |
100,000
-6.85%
|
$400,000
$4.07 P/Share
|
|
Jun 09
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Open market or private sale
|
Direct |
100,000
-7.99%
|
$400,000
$4.08 P/Share
|
|
May 06
2025
|
Andrew Lauck Director |
BUY
Grant, award, or other acquisition
|
Direct |
83,264
+37.29%
|
-
|
|
May 06
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Direct |
8,253
+2.83%
|
-
|
|
Mar 28
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
27,777
+2.17%
|
$0
$0.18 P/Share
|
|
Mar 27
2025
|
Robert S Wiesenthal Director |
SELL
Payment of exercise price or tax liability
|
Direct |
717,815
-10.92%
|
$1,435,630
$2.98 P/Share
|
|
Mar 27
2025
|
Robert S Wiesenthal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,237,611
+15.85%
|
$0
$0.18 P/Share
|
|
Mar 26
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
27,779
+2.22%
|
$0
$0.18 P/Share
|
|
Mar 13
2025
|
Scott M Wunsch CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,575
-0.93%
|
$7,725
$3.12 P/Share
|
|
Mar 13
2025
|
William A. Heyburn Co-CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
160,075
-5.03%
|
$480,225
$3.12 P/Share
|
|
Mar 13
2025
|
William A. Heyburn Co-CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
222,857
+12.09%
|
-
|
|
Mar 13
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
166,617
-6.25%
|
$499,851
$3.12 P/Share
|
|
Mar 13
2025
|
Melissa M. Tomkiel Co-CEO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
257,143
+15.88%
|
-
|
|
Mar 13
2025
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,069
-15.2%
|
$96,207
$3.12 P/Share
|
|
Mar 13
2025
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,428
+31.67%
|
-
|
|
Mar 13
2025
|
Robert S Wiesenthal Director |
SELL
Payment of exercise price or tax liability
|
Direct |
309,692
-2.78%
|
$929,076
$3.12 P/Share
|
|
Mar 13
2025
|
Robert S Wiesenthal Director |
BUY
Grant, award, or other acquisition
|
Direct |
394,286
+6.53%
|
-
|